Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Playtika Holding Corp.Playtika Reports $2.7554 Billion Revenue with Net Loss of $206.4 Million for 2025
Archrock, Inc.Archrock Reports 29% Revenue Growth to $1.49 Billion for Fiscal Year 2025
Disc Medicine, Inc.Disc Medicine Reports $212.2 Million Net Loss and Progress on Clinical Trials in Annual Filing
ALKAMI TECHNOLOGY, INC.Alkami Technology Reports 32.9% Revenue Growth to $443.6 Million for Fiscal Year 2025
MEDICAL PROPERTIES TRUST INCMedical Properties Trust Reports $277 Million Net Loss for 2025
Pulmatrix, Inc.Pulmatrix Reports $5.2 Million Net Loss for Fiscal Year 2025, Enters Merger Agreement with Cullgen
CRA INTERNATIONAL, INC.CRA International Reports 9.3% Revenue Growth to $751.6 Million for Fiscal Year Ending January 3, 2026
MANNKIND CORPMannKind Corporation Reports 22% Revenue Growth to $348.97 Million for Fiscal Year 2025
Pennant Group, Inc.Pennant Group Reports 36.3% Revenue Growth to $947.7 Million for Fiscal Year 2025
HERON THERAPEUTICS, INC. /DE/Heron Therapeutics Reports $20.2 Million Net Loss and 7.4% Revenue Growth for Fiscal Year 2025
International Seaways, Inc.International Seaways Reports Shipping Revenues of $843.3 Million for 2025
Edgewise Therapeutics, Inc.Edgewise Therapeutics Reports $167.8 Million Net Loss for 2025, Advances Clinical Programs
Burford Capital LtdBurford Capital Reports 24% Revenue Decline and 57% Drop in Net Income for Fiscal Year 2025
Lantheus Holdings, Inc.Lantheus Holdings Reports $1.542 Billion in Revenue for 2025, Net Income Declines 25.2%
C4 Therapeutics, Inc.C4 Therapeutics Reports $105M Net Loss and $35.9M Revenue for Fiscal Year 2025
Wave Life Sciences Ltd.Wave Life Sciences Reports 2025 Financial Results and Strategic Developments
Akebia Therapeutics, Inc.Akebia Therapeutics Reports 49% Revenue Growth to $227.3 Million in 2025
Cronos Group Inc.Cronos Group Inc. Reports 25% Revenue Growth to $146.6 Million for Fiscal Year 2025
EMCOR Group, Inc.EMCOR Group Reports 16.6% Revenue Growth to $16.99 Billion for Fiscal Year 2025
COLLEGIUM PHARMACEUTICAL, INCCollegium Pharmaceutical Reports 24% Revenue Growth to $780.6 Million for Fiscal Year 2025
NOVAVAX INCNovavax Reports $1.1 Billion Revenue and $440.3 Million Net Income for Fiscal Year 2025
Thryv Holdings, Inc.Thryv Holdings Reports $785M Revenue Decline, Shifts Focus to SaaS
Vital Farms, Inc.Vital Farms Reports 25% Revenue Growth to $759.4 Million in Latest 10-K Filing
NCR VOYIX CorpNCR Voyix Reports $2.7 Billion Revenue for Fiscal Year 2025, 5% Decrease from 2024
FTI CONSULTING, INCFTI Consulting Reports 2.4% Revenue Increase to $3.79 Billion for Fiscal Year 2025